Jane Peppard
Aventis Pharmaceuticals
Mailstop: JR1-303C
P.O. Box 6800
Route 202-206
USA
Name/email consistency: high
- Development of a high-throughput screening assay for inhibitors of aggrecan cleavage using luminescent oxygen channeling (AlphaScreen ). Peppard, J., Glickman, F., He, Y., Hu, S.I., Doughty, J., Goldberg, R. J. Biomol. Screen (2003)
- Development of an assay suitable for high-throughput screening to measure matrix metalloprotease activity. Peppard, J., Pham, Q., Clark, A., Farley, D., Sakane, Y., Graves, R., George, J., Norey, C. Assay. Drug. Dev. Technol (2003)